Skip to content

VADIVARHE SPECIALITY CHEMICALS LTD. (VSCL)

SME Cap

Industrials stocks · SME cap · NSE

VADIVARHE SPECIALITY CHEMICALS LTD. operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹24.9
+1.15 · +4.84%
Market cap ₹29.5 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm IST
Details
Quote21 Oct, 03:31 pm IST
Base fundamentals11 Oct 2026 · screener
Latest result01 Jun, 08:01 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags24 Apr 2026
Coverage11/14 · 79%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

48Neutral

SMA20 -19.0% / mo · MACD +

Stock trend: 50
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

VSCLD candles · FIT view-2.0%
Latest close ₹24.90 on 2026-10-21
Bar
+0.0%
RSI
60
MACD hist
0.61
52W pos
56%
Visible chart range
Candle interval
2026-10-21O ₹24.90H ₹24.90L ₹24.90C ₹24.90Vol 6,000 sh
₹18.57₹22.04₹25.50₹28.96₹32.4352H₹24.90VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

VSCLNifty India ManufacturingNifty 500
-37%-21%-6%+9%24 Jul27 Aug21 Oct21 Oct 2026VSCL -14.1%Nifty India Manufactu… -6.4%Nifty 500 -4.8%
VSCL
-14.1%
Nifty 500
-4.8%
Nifty India Manufacturing
-6.4%
Vs Nifty 500
-9.4 pp
Chart stats
21 Oct 2026
From 52W high
-25.4%
₹33.4
52W range position
51%
₹16.1 - ₹33.4
ATR (14)
4.1%
₹1
Volume vs 20D
1.03x
Latest completed session
Avg traded value
₹0 Cr
20-session average
20D price channel
₹19.2 - ₹24.9
69.2% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED
18

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Bad
15

Revenue +10.6% · PAT -42.0% YoY

Technical
Neutral
48

Price trend and sector-relative-strength timing.

Valuation
Legacy model
—

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
62

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 31 Mar 2026

Bad · 15/100

PAT -42% YoY · Rev +11% YoY · margin expansion · +69% QoQ

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹28.7 Cr+10.6%+68.7%
EBITDA₹3.1 CrNDF+225.2%
Operating margin10.7%NDF+2516 bps
PAT₹2.2 Cr-42.0%NDF
PAT margin7.7%NDF+3028 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
—
P/B
—
EV/EBITDA
22.95
Market Cap
29.50Cr

Profitability

ROE
—
ROCE
-1.32%
ROA
-4.23%
Dividend Y
—

Growth (CAGR)

Revenue 5Y
12.00%
EPS 5Y
8.00%
Revenue 3Y
2.00%
EPS 3Y
-21.00%

Balance Sheet

Debt/Equity
0.00
Interest Coverage
0.55×
Altman Z
1.04
Book Value
-3.46

Cash Flow

FCF Yield
19.42%
FCF Positive Y
7/5
OCF
6.36 Cr
EPS TTM
-1.28

Shareholding

Promoter Hold
71.73%
Promoter Pledge
0.00%
Momentum 52W
23%

Financial History

Updated 21/10/2026

Revenue

₹ Cr
Latest: 28.7+68.7% vs prev
028.7Sep 2020: 13.8Mar 2021: 12.6Sep 2021: 9.8Mar 2022: 11.6Sep 2022: 21.4Mar 2023: 22.3Sep 2023: 14.1Mar 2024: 26.0Sep 2024: 14.5Mar 2025: 23.4Sep 2025: 17.0Mar 2026: 28.7Q2 20FY21Q2 21FY22Q2 22FY23Q2 23FY24Q2 24FY25Q2 25FY26

Net Profit

₹ Cr
Latest: 2.2+157.4% vs prev
-6.003.8Sep 2020: -1.1Mar 2021: -1.7Sep 2021: -4.0Mar 2022: -5.6Sep 2022: 0.2Mar 2023: 1.0Sep 2023: -3.8Mar 2024: 3.8Sep 2024: -3.3Mar 2025: -6.0Sep 2025: -3.9Mar 2026: 2.2Q2 20FY21Q2 21FY22Q2 22FY23Q2 23FY24Q2 24FY25Q2 25FY26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 60. Wait for confirmation.

  • SMA20 falling (~23.4% over last month) — short-term momentum negative.
  • RSI(14) at 60 — rising, no extreme reading.
  • MACD above signal, histogram expanding — bullish momentum building.
  • 22% off 52W high · 55% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

55
RS percentile
Insufficient history
1M return
+20.6%
3M return
-2.0%
6M return
-11.1%
1Y return
-
RS 1D
+18
RS 20D
-
Sector rank
#2
Industry rank
#6
Stage evidence
  • At least 170 daily sessions are required for the trend-stage read.
50-DMA
price above
200-DMA
unavailable
Sector
leading
Industry
leading
Partial-history RS: the 3M and 6M weights are re-normalised because 12M history is unavailable.
Relative-strength line vs Nifty 500 (base 100)
121 observations
21 Oct 2026Value 92.6+5.82%
52678297112Sept 25Feb 26Jun 26Oct 2693
RS vs Nifty 50093

Valuation & peers

U-Score 18 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

18U-SCORE
Distress Watch

Fundamental score breakdown

U band · OVERVALUED
Valuation2/30
Growth8/25
Quality0/20
Balance Sheet5/15
Cash Flow8/10
Piotroski
6/9 (+3)
Penalties
-8
Raw sum
18

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

18/100 · legacy band OVERVALUED

Positive drivers

  • FCF yield is supportive at 19.4%.
  • Cash flow contributes 8/10 to the score.
  • Balance sheet contributes 5/15 to the score.

Main drags

  • Altman Z is 1.0, in distress territory.
  • Penalty bucket subtracts 8 points.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
—
PB
—
EV/EBITDA
22.9
ROE
—
ROCE
-1.3%
FCF Yield
19.4%
Debt/Equity
0.0
MoS
—
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
18
Previous: 18
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
—
No stored baseline yet

Score history

12 stored score snapshots. Latest stored move: +0 points.

21 Oct 2026
v4.3-runtime-valuation
18
18
18
18
18
18
18
18
18
18
18
18

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
—
Growth-justified P/E
19.6
Growth-justified Value
—
— MoS
PEG
—

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
MCON
SME
Mcon Rasayan India Ltd.
Specialty Chemicals
match 164
60
9.8
8.8%
+75%
UNDERVALUED
YCCL
SME
Yasons Chemex Care Ltd.
Specialty Chemicals
match 163
22
17.5
2.3%
-839%
OVERVALUED
UNILEX
SME
Unilex Colours and Chemicals Ltd.
Specialty Chemicals
match 162
36
5.0
10.4%
+32%
WATCHLIST
SNEHAA
SME
Snehaa Organics Ltd.
Specialty Chemicals
match 158
77
5.6
24.2%
+87%
DEEP VALUE
RITEZONE
SME
Rite Zone Chemcon India Ltd.
Specialty Chemicals
match 158
53
21.2
2.2%
+43%
FAIR VALUE

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

VADIVARHE SPECIALITY CHEMICALS LTD. operates in Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
62Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 35th percentile of the scored universe and 32nd percentile within Industrials. Main check: financial discipline is weak at 30/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
0 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
35th percentile

overall median 67 · Industrials: 32nd pctile, median 68 · SME: 41st pctile, median 64

Evidence depth
Financial-only

0 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
90
strong · holding, pledge, alignment
Cash flow
89
strong · profit to cash conversion
Balance sheet
48
watch · leverage and solvency
Discipline
30
weak · capital discipline
Results
43
weak · quarterly consistency

Trust positives

  • ▸Promoter holding is 71.7%.
  • ▸Promoter pledge is zero.
  • ▸Promoter holding increased 4.9%.
  • ▸FCF yield is 18.3%.

Trust risks

  • ▸Altman Z is 1.05.
  • ▸3 latest quarters had PAT decline worse than 25% YoY.
  • ▸Interest coverage is 0.5x.
  • ▸ROCE is low at -2%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

2 shown
Annual reportMar 2026

Mar 2026 · Annual Report 2026

Source: Nse

Open source ↗
Annual reportMar 2025

Mar 2025 · Annual Report 2025

Source: Nse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.